Generex Congratulates their Shareholders as FINRA has Officially Posted the Approval of the Generex Corporate Action and Payment of the Generex and NuGenerex Immuno-Oncology Stock Dividends on Monday, February 24, 2020


You May Also Like

Loxo Oncology to Announce Third Quarter 2017 Financial Results and Host Conference Call

STAMFORD, Conn., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

Epistem management buy-out

MANCHESTER, United Kingdom, June 12, 2018 (GLOBE NEWSWIRE) -- Epistem, the Manchester UK-based Contract ...